相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Sham Mailankody et al.
BLOOD (2011)
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis
Agnieszka Vay et al.
GYNECOLOGIC ONCOLOGY (2011)
Time To Remember To Forget Dose-Intensification in Lymphoma
Bruce D. Cheson
JOURNAL OF CLINICAL ONCOLOGY (2011)
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
Corrado Tarella et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
P. Kapoor et al.
LEUKEMIA (2011)
Clinical radioimmunotherapy-the role of radiobiology
Jean-Pierre Pouget et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Risks of second primary cancer among patients with major histological types of lung cancers in both men and women
S-C Chuang et al.
BRITISH JOURNAL OF CANCER (2010)
Incidence and susceptibility to therapy-related myeloid neoplasms
Giuseppe Leone et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Therapy-related leukemia following chemoradiotherapy for esophageal cancer
Naoya Mimura et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype
Lindsay M. Morton et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Therapy-Related Myeloid Neoplasms
Magdalena Czader et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
New avenues for second-line treatment of metastatic non-small-cell lung cancer
Cesare Gridelli et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Acute myelogenous leukemia following treatment of invasive cervix carcinoma: A case report and a review of the literature
Dipti R. Samanta et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Andreas Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Present status and future direction of clinical trials in advanced endometrial carcinoma
Howard D. Homesley
Journal of Gynecologic Oncology (2008)
Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
Anand Rajeswaran et al.
LUNG CANCER (2008)
Early chemotherapy in prostate cancer
Danish Mazhar et al.
NATURE CLINICAL PRACTICE UROLOGY (2008)
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group
Smita Bhatia et al.
BLOOD (2007)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide
C Praga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma
DP Cronin et al.
HEMATOLOGICAL ONCOLOGY (2005)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the united states
LC Harlan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers
Y Yasui et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation
V Delwail et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
International Workshop on the Relationship of Prior Therapy to Balanced Chromosome Aberrations in Therapy-Related Myelodysplastic Syndromes and Acute Leukemia: Overview report
JD Rowley et al.
GENES CHROMOSOMES & CANCER (2002)
Adjuvant therapy for breast cancer: Practice patterns of community physicians
LC Harlan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
EA Stadtmauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
